Imaging Technology

JANUARY 5, 2024

milla1cf Fri, 01/05/2024 - 11:32 January 5, 2024 — NorthStar Medical Radioisotopes, LLC , a global innovator in development, production and commercialization of radiopharmaceuticals used to detect and treat cancer and other serious diseases, and Curadh MTR Inc. Chief Executive Officer of NorthStar Medical Radioisotopes.

Radiopharmaceuticals 52

Radiopharmaceuticals Medical Nuclear Medicine Pharmaceutical 52

Imaging Technology

JUNE 10, 2024

milla1cf Mon, 06/10/2024 - 18:25 June 10, 2024 — Jean-Luc C. SNMMI introduced a new slate of officers during its 2024 Annual Meeting, held June 8-11 in Toronto. “As As SNMMI president-elect, I plan to focus on bringing and integrating radiopharmaceutical theranostics into the clinic to benefit as many patients as possible. “As

Nuclear Medicine 59

Nuclear Medicine Radiopharmaceuticals Hospital Health Science 59

Radiology Business

JULY 14, 2023

The agency issued its solicitation as part of the 2024 Hospital Outpatient Prospective Payment System proposed rule, released late Thursday.

Radiopharmaceuticals 83

Radiopharmaceuticals Diagnostic Hospital IT 83

Imaging Technology

JUNE 7, 2024

milla1cf Fri, 06/07/2024 - 14:57 June 7, 2024 — Shine Technologies, LLC , a pioneer in next-generation fusion-based technology, today announced a new partnership with Blue Earth Therapeutics , a Bracco company and recognized leader in the development of innovative radiopharmaceuticals. Statistically, approximately 12.9%

IT 85

IT Radiopharmaceuticals Clinic Diagnose 85

AuntMinnie

MARCH 7, 2024

year over year, according to the newly published IMV 2024 PET Market Summary Report. In terms of 2023 spending, the average radiopharmaceutical expenditure per fixed PET site is estimated to be $517,000. IMV's 2024 PET Market Summary Report explores market trends in U.S. Davin Korstjens.

PET Scan 115

PET Scan Nuclear Medicine Radiation Oncology Radiopharmaceuticals 115

AuntMinnie

JUNE 11, 2024

TORONTO – The radiopharmaceutical Pluvicto improves progression-free survival in patients with metastatic prostate cancer who haven’t undergone taxane therapy, according to research presented at the SNMMI meeting. Oliver Sartor, MD The study, which was awarded SNMMI’s Abstract of the Year award, shared data from the phase III PSMAfore trial.

Nuclear Medicine 122

Nuclear Medicine Radiopharmaceuticals Radiograph Radiographer 122

AuntMinnie

APRIL 4, 2024

The RLS radiopharmacy network will use these generators to produce gallium-68-based (Ga-68) radiopharmaceuticals for PET imaging and treatment planning for patients with neuroendocrine tumors and prostate cancer. RLS added that it is also building a national distributed radiopharmaceutical contract development and manufacturing network.

Radiopharmaceuticals 52

Radiopharmaceuticals IT Medical Imaging 52

Imaging Technology

FEBRUARY 21, 2024

milla1cf Wed, 02/21/2024 - 18:58 February 21, 2024 — Blue Earth Therapeutics , a Bracco company and emerging leader in the development of innovative next generation therapeutic radiopharmaceuticals, is pleased to share the publication of promising early clinical data with 177Lu-rhPSMA-10.1 177Lu-rhPSMA-10.1

Clinic 81

Clinic Radiopharmaceuticals Nuclear Medicine Hospital 81

AuntMinnie

JUNE 10, 2024

Evans, PhD, has been named the 2024 recipient of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Sam Gambhir Trailblazer Award. He will be honored at the SNMMI's annual meeting in Toronto. Evans earned his PhD in organic chemistry from the Scripps Research Institute.

Nuclear Medicine 40

Nuclear Medicine Radiopharmaceuticals Pharmaceutical Clinic 40

Imaging Technology

JANUARY 12, 2024

milla1cf Fri, 01/12/2024 - 11:09 January 12, 2024 — RefleXion Medical , Inc., 1, 2024, to describe SCINTIX therapy. The first code, C9794, defines a separate pre-treatment procedure in which radiopharmaceutical emissions data is collected for use in creating the SCINTIX treatment delivery plan.

Radiopharmaceuticals 100

Radiopharmaceuticals Radiation Medicare Clinic 100

Imaging Technology

JULY 5, 2024

mtaschetta-millane Fri, 07/05/2024 - 06:00 July 5, 2024 — Lantheus Holdings, Inc. , For more information: www.lantheus.com Friday, July 5, 2024 - 06:00

Diagnostic 52

Diagnostic Radiopharmaceuticals Disease IT 52

Imaging Technology

MAY 17, 2024

milla1cf Fri, 05/17/2024 - 18:43 May 17, 2024 — Registration opens today for the American Society for Radiation Oncology's ( ASTRO ) 66th Annual Meeting, which will be held at the Walter E. September 29 – October 2, 2024. Washington Convention Center in Washington, D.C.,

Radiation Oncology 52

Radiation Oncology Radiation Radiopharmaceuticals Education 52

Imaging Technology

MAY 14, 2024

milla1cf Tue, 05/14/2024 - 12:45 May 14, 2024 — University Hospitals (UH) and Siemens Healthineers announce a 10-year strategic alliance that builds on their 40-year history of clinical and research collaboration. Because there is no “typical” hospital or laboratory and many variables exist (e.g.,

Hospital 103

Hospital Magnetic Resonance Imaging Radiopharmaceuticals Disease 103

AuntMinnie

APRIL 15, 2024

increase in nonhospital-based studies, according to the newly published IMV 2024 NM Market Outlook Report. According to the report, this year 14% of nuclear medicine sites are currently performing theranostics procedures, with the top two radiopharmaceuticals used being Y-90 microspheres and iodine-131. Nonhospitals 2.5%

Nuclear Medicine 111

Nuclear Medicine Hospital Radiopharmaceuticals Radiologist 111

Imaging Technology

FEBRUARY 14, 2024

milla1cf Wed, 02/14/2024 - 18:28 February 14, 2024 — PanTera , the Belgian joint venture created by IBA and SCK CEN to secure large-scale production of alpha-emitting radioisotopes, today announces the signing of a capacity reservation agreement with Bayer for the supply of actinium-225 (225Ac) starting in the second half of 2024.

Pharmaceutical 84

Pharmaceutical Radiopharmaceuticals Medical Clinic 84

AuntMinnie

FEBRUARY 7, 2024

E Solutions, also based in Indianapolis, is a company that specializes in executing multiple FDA-regulated installations in the radiopharmaceutical industry. Isotopia anticipates providing products to its key customers in the fourth quarter of 2024, the company added.

Nuclear Medicine 52

Nuclear Medicine Radiopharmaceuticals IT Medical 52

Imaging Technology

JANUARY 23, 2024

For more information: www.iba-worldwide.com Tuesday, January 23, 2024 - 13:47 If you enjoy this content, please share it with a colleague We see a growing interest for these high energy machines, driven by an increasing number of clinical trials exploring new diagnostic or radiotherapeutic molecules.”

Radiopharmaceuticals 96

Radiopharmaceuticals Disease Diagnostic Clinic 96

AuntMinnie

OCTOBER 10, 2023

Under the terms of the agreement, PharmaLogic will have access to Eckert & Ziegler's high-purity, non-carrier-added Ac-225, an active substance in cancer treatment, for the labeling of radiopharmaceuticals for research and development work and commercial use.

Radiopharmaceuticals 52

Radiopharmaceuticals 52

Imaging Technology

AUGUST 31, 2023

milla1cf Thu, 08/31/2023 - 15:50 August 31, 2023 — NorthStar Medical Radioisotopes , LLC, a global innovator in the development, production and commercialization of radiopharmaceuticals, and Curadh MTR Inc. Ac-225 for use in radiopharmaceutical therapy (RPT). actinium-225 (Ac-225). “As a company at the forefront of U.S.

Medical 91

Medical Radiopharmaceuticals Pharmaceutical Radiation 91

Imaging Technology

AUGUST 28, 2023

While continuing to prepare our unique technology for large-scale production of 225Ac, as from 2024 we will also offer the radioisotope to drug developers for their research and clinical trials, as well as to physicians for compassionate use.

Radiopharmaceuticals 94

Radiopharmaceuticals Pharmaceutical Clinic Medical 94

Imaging Technology

JULY 5, 2023

Ac-225 is a high energy alpha-emitting radioisotope of increasing interest for clinical studies investigating the use of targeted radiopharmaceutical therapy, which combines select molecules with therapeutic radioisotopes to directly target and deliver therapeutic doses of radiation to destroy cancer cells in patients with serious disease.

Medical 63

Medical Radiopharmaceuticals Pharmaceutical Radiation 63

AuntMinnie

JUNE 9, 2024

She has co-authored more than 200 articles, focusing on developing radiopharmaceuticals for oncological imaging and therapy, the society said. Aebersold Award for outstanding achievement for basic science research applied to nuclear medicine in 2020; and the Glenn T.

Nuclear Medicine 98

Nuclear Medicine Radiopharmaceuticals Disease Imaging 98

AuntMinnie

DECEMBER 11, 2023

Effective January 1, 2024, t he firms will be leaving the National Electrical Manufacturing Association (NEMA), which has housed MITA since 2007. We are bringing all of the imaging work [previously done at MITA] into AdvaMed under the AdvaMed umbrella,” said AdvaMed President and CEO Scott Whitaker.

Imaging 109

Imaging Medical Imaging Radiopharmaceuticals Medical 109

AuntMinnie

JUNE 10, 2024

In 2024, she was part of the team that was awarded the Department of Energy Secretarial Honors award for its work on actinium-225 (Ac-225). She also intends to create training and education opportunities in theranostics and to educate the public on nuclear medicine and its value. Cutler's awards are many.

Nuclear Medicine 40

Nuclear Medicine Radiopharmaceuticals Education Diagnostic 40

Imaging Technology

APRIL 2, 2024

milla1cf Tue, 04/02/2024 - 18:51 April 2, 2024 — Less than three months after signing an agreement to acquire MIM Software Inc. , GE HealthCare Technologies Inc. iv See our latest earnings release dated February 6, 2024 for the definition of Adjusted EBIT. Journal of European Urology.

Healthcare 95

Healthcare Healthcare Radiation Oncology Magnetic Resonance Imaging 95

Imaging Technology

OCTOBER 18, 2023

The joint venture remains subject to further closing conditions expected to be satisfied in early 2024. Targeted radiopharmaceuticals are created by linking a therapeutic radioisotope to a targeting molecule (e.g., a new joint venture company between CNL and ITM for the industrial scale production of Actinium-225 (225Ac).

Radiopharmaceuticals 94

Radiopharmaceuticals Pharmaceutical Radiation Medical 94

AuntMinnie

MARCH 26, 2024

Food and Drug Administration's (FDA) approvals of radiopharmaceuticals for neuroendocrine tumors and then for prostate cancer, theranostics has picked up momentum in clinical practice, propelled by encouraging research. Since 2013 we've had several more radiopharmaceutical therapies get FDA approval. Since the U.S.

Nuclear Medicine 122

Nuclear Medicine Radiopharmaceuticals Radiation Health Science 122

Imaging Technology

APRIL 10, 2024

The data were presented in a poster presentation at the American Association for Cancer Research (AACR) Annual Meeting 2024 in San Diego, Calif. drug combinations with the scientific community at the prestigious AACR Annual Meeting 2024,” said David E. Blue Earth Group, Oxford, UK, at the AACR Annual Meeting 2024 on April 7, 2024.

Radiopharmaceuticals 92

Radiopharmaceuticals Radiosensitivity Medical Diagnostic 92

Imaging Technology

JUNE 20, 2024

When produced in combination with the company’s TRACERcenter – which is designed to serve as a complete PET radiopharmacy solution – the resulting radiopharmaceuticals can help physicians identify and diagnose clinical signs across care areas – including oncology, cardiology, and neurology.

Healthcare 80

Healthcare Healthcare Nuclear Medicine Computed Tomography 80

AuntMinnie

JUNE 20, 2024

Food and Drug Administration's (FDA) approvals of radiopharmaceuticals for neuroendocrine tumors and then for prostate cancer, theranostics has picked up momentum in clinical practice, propelled by encouraging research. Since 2013 we've had several more radiopharmaceutical therapies get FDA approval. Since the U.S.

Nuclear Medicine 52

Nuclear Medicine Radiopharmaceuticals Radiation Health Science 52

AuntMinnie

APRIL 4, 2024

A decade ago, only a few radiopharmaceutical agents were used to help treat cancer patients. He also helped lead the theranostics conference at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2024 midwinter meeting. However, few freestanding theranostics centers exist today.

Nuclear Medicine 86

Nuclear Medicine Radiation Oncology Nursing Radiation 86

AuntMinnie

JUNE 9, 2024

As SNMMI president-elect, I plan to focus on bringing and integrating radiopharmaceutical theranostics into the clinic to benefit as many patients as possible," Urbain said in an SNMMI announcement. Jean-Luc Urbain, MD, PhD. “As

Nuclear Medicine 40

Nuclear Medicine Radiopharmaceuticals Government Education 40

AuntMinnie

JANUARY 30, 2024

Effective January 1, 2024, the new codes, 0865T and 0866T, support the use of software to analyze brain MRI exams with comparison to prior studies. A widely used class of radiopharmaceuticals in the study of the neuroinflammatory response targets the translocator protein (TSPO), according to the researchers.

MRI 100

MRI Radiopharmaceuticals Disease Imaging 100

Imaging Technology

JUNE 13, 2024

milla1cf Thu, 06/13/2024 - 20:53 June 13, 2024 — The Society of Nuclear Medicine and Molecular Imaging (SNMMI) hosted more than 8,000 physicians, technologists, pharmacists, laboratory professionals, scientists and others earlier this week at its 2024 Annual Meeting in Toronto, Ontario. Themed “Innovate. Illuminate.”,

Nuclear Medicine 75

Nuclear Medicine Radiopharmaceuticals Education Imaging 75

Imaging Technology

APRIL 3, 2023

Mr. Merrick continued, “Demand for therapeutic radiopharmaceuticals is increasing rapidly. NorthStar has further deepened and broadened our business platform with the recent establishment of a full-scale radiopharmaceutical CDMO/CMO services unit. Ac-225 using advanced, environmentally preferable electron accelerator technology.

Medical 82

Medical Radiopharmaceuticals Pharmaceutical Radiation 82

AuntMinnie

JUNE 3, 2024

With therapeutic radiopharmaceuticals coming to market quickly and available to smaller institutions around the U.S., My vision of a theranostic center includes a flagship facility that has a PET/CT scanner, a SPECT/CT scanner, and then multiple rooms for infusions of radiopharmaceuticals," Siegel explained.

Nuclear Medicine 105

Nuclear Medicine Radiopharmaceuticals Radiation Radiation Oncology 105

Imaging Technology

FEBRUARY 15, 2024

mtaschetta-millane Thu, 02/15/2024 - 12:50 February 15, 2024 — According to a release issued by the U.S. A rescan or re-injection of radiopharmaceutical to the patient may be required. Thursday, February 15, 2024 - 12:50 If you enjoy this content, please share it with a colleague

Computed Tomography 66

Computed Tomography Imaging Medical Device Radiopharmaceuticals 66